Invasive Giant Prolactinoma.
Dopamine
Hormonal
Pituitary
Prolactinoma
Journal
World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275
Informations de publication
Date de publication:
11 Oct 2023
11 Oct 2023
Historique:
received:
08
07
2023
revised:
04
10
2023
accepted:
05
10
2023
pubmed:
13
10
2023
medline:
13
10
2023
entrez:
12
10
2023
Statut:
aheadofprint
Résumé
A 64-year-old man presented with an 8-year history of decreased libido, impotence, and blurred vision. The neurologic examination revealed a mild left facial weakness, visual acuity of (20/60), and right homonymous hemianopia. Laboratory investigation of serum prolactin was 7896 ng/mL. Testosterone, free T4, and adrenocorticotropic hormone were all decreased. Brain magnetic resonance imaging showed a giant sellar/suprasellar lesion, compressing on the brainstem and extending to the cerebellopontine angle. A diagnosis of panhypopituitarism secondary to a giant macroprolactinoma was made. The patient was started on hormonal replacement therapy and underwent craniotomy and tumor resection. The histopathologic findings were compatible with prolactinoma. Invasive giant prolactinomas are defined as 1) tumor size of >4 cm in diameter; 2) serum prolactin of >1000 ng/mL; and 3) mass effect or hyperprolactinemia-induced symptomatology. The management of invasive giant prolactinoma commonly comprises a multimodal approach of both medical treatment and surgical intervention.
Identifiants
pubmed: 37827431
pii: S1878-8750(23)01431-6
doi: 10.1016/j.wneu.2023.10.025
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21-22Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.